A detailed history of New Edge Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 10,746 shares of DXCM stock, worth $837,543. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,746
Previous 9,020 19.14%
Holding current value
$837,543
Previous $1.02 Million 29.55%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $110,464 - $200,319
1,726 Added 19.14%
10,746 $720,000
Q2 2024

Aug 15, 2024

BUY
$110.31 - $140.45 $153,661 - $195,646
1,393 Added 18.26%
9,020 $1.02 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $59,622 - $73,132
522 Added 7.35%
7,627 $1.06 Million
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $3,925 - $6,456
-52 Reduced 0.73%
7,105 $881,000
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $251,897 - $403,721
2,927 Added 69.2%
7,157 $667,000
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $44,200 - $51,475
393 Added 10.24%
4,230 $543,000
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $248,352 - $293,532
-2,388 Reduced 38.36%
3,837 $445,000
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $529,000 - $763,620
6,225 New
6,225 $704,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $158,712 - $219,647
-1,687 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$129.87 - $162.82 $219,090 - $274,677
1,687 New
1,687 $906,000
Q4 2020

Jan 27, 2021

SELL
$78.0 - $104.5 $114,348 - $153,197
-1,466 Closed
0 $0
Q3 2020

Nov 03, 2020

SELL
$95.51 - $112.95 $157,878 - $186,706
-1,653 Reduced 53.0%
1,466 $604,000
Q2 2020

Jul 29, 2020

BUY
$62.68 - $105.34 $100,476 - $168,860
1,603 Added 105.74%
3,119 $1.26 Million
Q1 2020

May 04, 2020

SELL
$47.79 - $75.63 $2,915 - $4,613
-61 Reduced 3.87%
1,516 $408,000
Q4 2019

Jan 31, 2020

SELL
$36.62 - $57.29 $8,312 - $13,004
-227 Reduced 12.58%
1,577 $344,000
Q3 2019

Nov 06, 2019

BUY
$35.53 - $43.8 $64,096 - $79,015
1,804 New
1,804 $283,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.